{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:08:27Z","timestamp":1791587307947,"version":"4.3.4"},"reference-count":78,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.revmed.2013.09.005","type":"journal-article","created":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T11:30:56Z","timestamp":1381923056000},"page":"746-753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Glycosylation des autoanticorps au cours des maladies auto-immunes"],"prefix":"10.1016","volume":"34","author":[{"given":"R.","family":"Goulabchand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Batteux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Guilpain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2013.09.005_bib0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","article-title":"The impact of glycosylation on the biological function and structure of human immunoglobulins","volume":"25","author":"Arnold","year":"2007","journal-title":"Ann Rev Immunol"},{"issue":"1","key":"10.1016\/j.revmed.2013.09.005_bib0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF01047890","article-title":"Structural study of the carbohydrate moieties of two human immunoglobulin subclasses (IgG2\u00a0and IgG4)","volume":"6","author":"Endo","year":"1989","journal-title":"Glycoconj J"},{"issue":"2","key":"10.1016\/j.revmed.2013.09.005_bib0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.imlet.2006.05.009","article-title":"Molecular aspects of human FcgammaR interactions with IgG\u00a0: functional and therapeutic consequences","volume":"106","author":"Sib\u00e9ril","year":"2006","journal-title":"Immunol Lett"},{"issue":"12","key":"10.1016\/j.revmed.2013.09.005_bib0020","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1038\/jid.2010.209","article-title":"The Thomsen-Friedenreich antigen-binding lectin jacalin interacts with desmoglein-1\u00a0and abrogates the pathogenicity of pemphigus foliaceus autoantibodies in vivo","volume":"130","author":"Li","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"1\u20132","key":"10.1016\/j.revmed.2013.09.005_bib0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jneuroim.2010.01.003","article-title":"MGAT5\u00a0alters the severity of multiple sclerosis","volume":"220","author":"Brynedal","year":"2010","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.revmed.2013.09.005_bib0030","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1073\/pnas.98.3.1142","article-title":"Genetic remodeling of protein glycosylation in vivo induces autoimmune disease","volume":"98","author":"Chui","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.revmed.2013.09.005_bib0035","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2567.2008.02898.x","article-title":"Alteration of N-glycosylation in the kidney in a mouse model of systemic lupus erythematosus: relative quantification of N-glycans using an isotope-tagging method","volume":"126","author":"Hashii","year":"2009","journal-title":"Immunology"},{"issue":"12","key":"10.1016\/j.revmed.2013.09.005_bib0040","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1136\/ard.2011.153130","article-title":"Antibodies recognising sulfated carbohydrates are prevalent in systemic sclerosis and associated with pulmonary vascular disease","volume":"70","author":"Grader-Beck","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.revmed.2013.09.005_bib0045","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1182\/blood-2005-05-1943","article-title":"Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change","volume":"107","author":"De Laat","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.revmed.2013.09.005_bib0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0304-4165(99)00166-X","article-title":"The alpha1-6-fucosyltransferase gene and its biological significance","volume":"1473","author":"Miyoshi","year":"1999","journal-title":"Biochim Biophys Acta"},{"issue":"30","key":"10.1016\/j.revmed.2013.09.005_bib0055","doi-asserted-by":"crossref","first-page":"26733","DOI":"10.1074\/jbc.M202069200","article-title":"Lack of fucose on human IgG1\u00a0N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shields","year":"2002","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.revmed.2013.09.005_bib0060","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.molimm.2006.09.005","article-title":"Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality","volume":"44","author":"Scallon","year":"2007","journal-title":"Mol Immunol"},{"issue":"5787","key":"10.1016\/j.revmed.2013.09.005_bib0065","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.revmed.2013.09.005_bib0070","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1021\/bp050228w","article-title":"Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro","volume":"21","author":"Hodoniczky","year":"2005","journal-title":"Biotechnol Prog"},{"issue":"9","key":"10.1016\/j.revmed.2013.09.005_bib0075","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1021\/bi00512a001","article-title":"Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution","volume":"20","author":"Deisenhofer","year":"1981","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.revmed.2013.09.005_bib0080","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0022-2836(02)01250-0","article-title":"Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity","volume":"325","author":"Krapp","year":"2003","journal-title":"J Mol Biol"},{"issue":"49","key":"10.1016\/j.revmed.2013.09.005_bib0085","doi-asserted-by":"crossref","first-page":"45539","DOI":"10.1074\/jbc.M107478200","article-title":"Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding","volume":"276","author":"Mimura","year":"2001","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.revmed.2013.09.005_bib0090","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jmb.2007.02.034","article-title":"Structural Comparison of Fucosylated and Nonfucosylated Fc Fragments of Human Immunoglobulin G1","volume":"368","author":"Matsumiya","year":"2007","journal-title":"J Mol Biol."},{"issue":"4","key":"10.1016\/j.revmed.2013.09.005_bib0095","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.coi.2008.06.007","article-title":"Terminal sugars of Fc glycans influence antibody effector functions of IgGs","volume":"20","author":"Raju","year":"2008","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"10.1016\/j.revmed.2013.09.005_bib0100","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nm0395-237","article-title":"Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein","volume":"1","author":"Malhotra","year":"1995","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.revmed.2013.09.005_bib0105","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.ajpath.2012.06.038","article-title":"Determination of Severity of Murine IgA Nephropathy by Glomerular Complement Activation by Aberrantly Glycosylated IgA and Immune Complexes","volume":"181","author":"Hashimoto","year":"2012","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.revmed.2013.09.005_bib0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1172\/JCI5535","article-title":"Circulating immune complexes in IgA nephropathy consist of IgA1\u00a0with galactose-deficient hinge region and antiglycan antibodies","volume":"104","author":"Tomana","year":"1999","journal-title":"J Clin. Invest."},{"key":"10.1016\/j.revmed.2013.09.005_bib0115","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000102455","article-title":"IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells","volume":"157","author":"Novak","year":"2007","journal-title":"Contrib Nephrol."},{"issue":"12","key":"10.1016\/j.revmed.2013.09.005_bib0120","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/ki.2011.276","article-title":"Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1\u00a0and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases","volume":"80","author":"Tissandi\u00e9","year":"2011","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.revmed.2013.09.005_bib0125","first-page":"622","article-title":"Glycosylation. Size of IgA1\u00a0Are Essential for Interaction with Mesangial Transferrin Receptor in IgA","volume":"15","author":"Moura","year":"2004","journal-title":"Nephropathy JASN"},{"issue":"17","key":"10.1016\/j.revmed.2013.09.005_bib0130","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0755-4982(04)98888-4","article-title":"[Immunomodulatory effects of intravenous immunoglobulins]","volume":"33","author":"Guilpain","year":"2004","journal-title":"Presse Med"},{"issue":"3","key":"10.1016\/j.revmed.2013.09.005_bib0135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10875-007-9088-9","article-title":"Intravenous immunoglobulin: an update on the clinical use and mechanisms of action","volume":"27","author":"Negi","year":"2007","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.revmed.2013.09.005_bib0140","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1196\/annals.1423.052","article-title":"Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective","volume":"1110","author":"Sib\u00e9ril","year":"2007","journal-title":"Ann. N.\u00a0Y. Acad. Sci."},{"issue":"Spec No 1","key":"10.1016\/j.revmed.2013.09.005_bib0145","first-page":"11","article-title":"[Immunoglobulins and physiopathology: actual indications]","volume":"28","author":"Mouthon","year":"2007","journal-title":"Rev Med Interne"},{"issue":"29","key":"10.1016\/j.revmed.2013.09.005_bib0150","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.2174\/138161211798157540","article-title":"Update on intravenous immunoglobulins (IVIg) mechanisms of action and off- label use in autoimmune diseases","volume":"17","author":"Katz","year":"2011","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.revmed.2013.09.005_bib0155","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1476-4431.2011.00676.x","article-title":"A review of current indications, adverse effects, and administration recommendations for intravenous immunoglobulin","volume":"21","author":"Spurlock","year":"2011","journal-title":"J Vet Emerg Crit Care (San Antonio)"},{"issue":"5","key":"10.1016\/j.revmed.2013.09.005_bib0160","first-page":"346","article-title":"Recommended indications for the administration of polyclonal immunoglobulin preparations","volume":"66","author":"Delforge","year":"2011","journal-title":"Acta Clin Belg."},{"issue":"3","key":"10.1016\/j.revmed.2013.09.005_bib0165","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1586\/eci.10.104","article-title":"Indications and safety of intravenous and subcutaneous immunoglobulin therapy","volume":"7","author":"Rezaei","year":"2011","journal-title":"Expert Rev Clin Immunol."},{"key":"10.1016\/j.revmed.2013.09.005_bib0170","unstructured":"Guilpain P, Kaveri SV, Mouthon L. Immunoglobulines intraveineuses. Trait\u00e9 des maladies syst\u00e9miques. Flammarion. p. 1309\u201327."},{"key":"10.1016\/j.revmed.2013.09.005_bib0175","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.immunol.26.021607.090232","article-title":"Anti-inflammatory actions of intravenous immunoglobulin","volume":"26","author":"Nimmerjahn","year":"2008","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.revmed.2013.09.005_bib0180","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/135245859700300211","article-title":"Modulation of autoimmune responses by intravenous immunoglobulin (IVIg)","volume":"3","author":"Kaveri","year":"1997","journal-title":"Mult. Scler."},{"issue":"2\u20133","key":"10.1016\/j.revmed.2013.09.005_bib0185","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.clim.2005.10.008","article-title":"Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory Fc gamma R functions","volume":"118","author":"Sib\u00e9ril","year":"2006","journal-title":"Clin. Immunol."},{"issue":"5874","key":"10.1016\/j.revmed.2013.09.005_bib0190","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1154315","article-title":"Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc","volume":"320","author":"Anthony","year":"2008","journal-title":"Science."},{"issue":"50","key":"10.1016\/j.revmed.2013.09.005_bib0195","doi-asserted-by":"crossref","first-page":"19571","DOI":"10.1073\/pnas.0810163105","article-title":"Identification of a receptor required for the anti-inflammatory activity of IVIG","volume":"105","author":"Anthony","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.\u00a0S. A."},{"issue":"7","key":"10.1016\/j.revmed.2013.09.005_bib0200","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/art.30362","article-title":"Sialylation levels of anti-proteinase 3\u00a0antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's)","volume":"63","author":"Espy","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"6027","key":"10.1016\/j.revmed.2013.09.005_bib0205","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/316452a0","article-title":"Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG","volume":"316","author":"Parekh","year":"1985","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.revmed.2013.09.005_bib0210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/clin.1994.1009","article-title":"Distribution of glycosylation abnormality among serum IgG subclasses from patients with rheumatoid arthritis","volume":"70","author":"Tsuchiya","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"4","key":"10.1016\/j.revmed.2013.09.005_bib0215","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/oxfordjournals.jbchem.a022794","article-title":"Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation","volume":"128","author":"Matsumoto","year":"2000","journal-title":"J.\u00a0Biochem."},{"issue":"2","key":"10.1016\/j.revmed.2013.09.005_bib0220","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio713","article-title":"Homomultimeric complexes of CD22\u00a0in B cells revealed by protein-glycan cross-linking","volume":"1","author":"Han","year":"2005","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.revmed.2013.09.005_bib0225","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-3083.1994.tb03442.x","article-title":"The binding of synovial tissue-derived human monoclonal immunoglobulin M rheumatoid factor to immunoglobulin G preparations of differing galactose content","volume":"40","author":"Soltys","year":"1994","journal-title":"Scand. J.\u00a0Immunol."},{"issue":"1","key":"10.1016\/j.revmed.2013.09.005_bib0230","first-page":"44","article-title":"Potential pathogenicity of deglycosylated IgG cross reactive with streptokinase and fibronectin in the serum of patients with rheumatoid arthritis","volume":"23","author":"Cuchacovich","year":"1996","journal-title":"J.\u00a0Rheumatol."},{"issue":"10","key":"10.1016\/j.revmed.2013.09.005_bib0235","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1002\/eji.200737581","article-title":"Endoglycosidase treatment abrogates IgG arthritogenicity: importance of IgG glycosylation in arthritis","volume":"37","author":"Nandakumar","year":"2007","journal-title":"Eur. J.\u00a0Immunol."},{"issue":"6","key":"10.1016\/j.revmed.2013.09.005_bib0240","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/art.27414","article-title":"Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid","volume":"62","author":"Scherer","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.revmed.2013.09.005_bib0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000112922","article-title":"Role of aberrant glycosylation of IgA1\u00a0molecules in the pathogenesis of IgA nephropathy","volume":"31","author":"Mestecky","year":"2008","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.revmed.2013.09.005_bib0250","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000422410","article-title":"Defective galactosylation and clearance of IgA1\u00a0molecules as a possible etiopathogenic factor in IgA nephropathy","volume":"104","author":"Mestecky","year":"1993","journal-title":"Contrib Nephrol."},{"issue":"3","key":"10.1016\/j.revmed.2013.09.005_bib0255","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-2249.1995.tb03724.x","article-title":"Galactosylation of N- and O-linked carbohydrate moieties of IgA1\u00a0and IgG in IgA nephropathy","volume":"100","author":"Allen","year":"1995","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.revmed.2013.09.005_bib0260","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1681\/ASN.V104760","article-title":"Underglycosylation of IgA1\u00a0hinge plays a certain role for its glomerular deposition in IgA nephropathy","volume":"10","author":"Hiki","year":"1999","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.revmed.2013.09.005_bib0265","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.semnephrol.2007.10.009","article-title":"IgA glycosylation and IgA immune complexes in the pathogenesis of IgA Nephropathy","volume":"28","author":"Novak","year":"2008","journal-title":"Semin Nephrol."},{"issue":"4","key":"10.1016\/j.revmed.2013.09.005_bib0270","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1084\/jem.20112005","article-title":"Transglutaminase is essential for IgA nephropathy development acting through IgA receptors","volume":"209","author":"Berthelot","year":"2012","journal-title":"J Exp Med."},{"issue":"2","key":"10.1016\/j.revmed.2013.09.005_bib0275","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2353\/ajpath.2007.060559","article-title":"Development of immunoglobulin A nephropathy- like disease in beta-1,4-galactosyltransferase-I-deficient mice","volume":"170","author":"Nishie","year":"2007","journal-title":"Am. J.\u00a0Pathol."},{"issue":"14","key":"10.1016\/j.revmed.2013.09.005_bib0280","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0755-4982(05)84104-1","article-title":"[Pathogenesis of primary systemic vasculitides (I): ANCA-positive vasculitides]","volume":"34","author":"Guilpain","year":"2005","journal-title":"Presse Med."},{"issue":"11","key":"10.1016\/j.revmed.2013.09.005_bib0285","first-page":"2246","article-title":"Alterations in the O-linked glycosylation of IgA1\u00a0in children with Henoch-Sch\u00f6nlein purpura","volume":"24","author":"Saulsbury","year":"1997","journal-title":"J.\u00a0Rheumatol."},{"issue":"6","key":"10.1016\/j.revmed.2013.09.005_bib0290","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1046\/j.1365-2141.2003.04539.x","article-title":"Immunoglobulin A multiple myeloma presenting with Henoch-Sch\u00f6nlein purpura associated with reduced sialylation of IgA1","volume":"122","author":"Van Der Helm-Van Mil","year":"2003","journal-title":"Br. J.\u00a0Haematol."},{"issue":"1","key":"10.1016\/j.revmed.2013.09.005_bib0295","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/ki.2011.16","article-title":"Aberrant glycosylation of IgA1\u00a0is inherited in both pediatric IgA nephropathy and Henoch-Sch\u00f6nlein purpura nephritis","volume":"80","author":"Kiryluk","year":"2011","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.revmed.2013.09.005_bib0300","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0896-8411(92)90151-F","article-title":"Galactose terminating oligosaccharides of IgG in patients with primary Sj\u00f6gren's syndrome","volume":"5","author":"Youinou","year":"1992","journal-title":"J.\u00a0Autoimmun."},{"issue":"39","key":"10.1016\/j.revmed.2013.09.005_bib0305","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1073\/pnas.0808248105","article-title":"In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner","volume":"105","author":"Albert","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.\u00a0S. A."},{"issue":"6","key":"10.1016\/j.revmed.2013.09.005_bib0310","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.4049\/jimmunol.145.6.1794","article-title":"Structural changes in the oligosaccharide chains of IgG in autoimmune MRL\/Mp-lpr\/lpr mice","volume":"145","author":"Mizuochi","year":"1990","journal-title":"J.\u00a0Immunol."},{"issue":"8","key":"10.1016\/j.revmed.2013.09.005_bib0315","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/art.34454","article-title":"IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: a possible new treatment\u00a0?","volume":"64","author":"Lood","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.revmed.2013.09.005_bib0320","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1182\/blood.V99.8.2922","article-title":"Level of galactosylation determines cryoglobulin activity of murine IgG3\u00a0monoclonal rheumatoid factor","volume":"99","author":"Kuroki","year":"2002","journal-title":"Blood."},{"issue":"11","key":"10.1016\/j.revmed.2013.09.005_bib0325","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1182\/blood.V97.11.3537","article-title":"Role of galactosylation in the renal pathogenicity of murine immunoglobulin G3\u00a0monoclonal cryoglobulins","volume":"97","author":"Mizuochi","year":"2001","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.revmed.2013.09.005_bib0330","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1021\/pr1004373","article-title":"IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis","volume":"10","author":"Selman","year":"2011","journal-title":"J.\u00a0Proteome Res."},{"issue":"11","key":"10.1016\/j.revmed.2013.09.005_bib0335","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.\u00a0S. A."},{"issue":"9","key":"10.1016\/j.revmed.2013.09.005_bib0340","doi-asserted-by":"crossref","first-page":"611","DOI":"10.7326\/0003-4819-147-9-200711060-00005","article-title":"Antiproteinase 3\u00a0antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis","volume":"147","author":"Finkielman","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.revmed.2013.09.005_bib0345","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.2006.062711","article-title":"EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"66","author":"Hellmich","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.revmed.2013.09.005_bib0350","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O","article-title":"Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study","volume":"43","author":"Boomsma","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.revmed.2013.09.005_bib0355","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.revmed.2013.09.005_bib0360","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/ard.2008.097758","article-title":"Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis","volume":"68","author":"Merkel","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.revmed.2013.09.005_bib0365","first-page":"1668","article-title":"Aberrantly glycosylated IgA1\u00a0in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity","volume":"119","author":"Suzuki","year":"2009","journal-title":"J Clin Invest."},{"issue":"5","key":"10.1016\/j.revmed.2013.09.005_bib0370","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1681\/ASN.2011060567","article-title":"Abnormal miR-148b Expression Promotes Aberrant Glycosylation of IgA1\u00a0in IgA Nephropathy","volume":"23","author":"Serino","year":"2012","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"10.1016\/j.revmed.2013.09.005_bib0375","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ana.23741","article-title":"Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4\u00a0immunoglobulin G into therapeutic antibody","volume":"73","author":"Tradtrantip","year":"2013","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.revmed.2013.09.005_bib0380","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1124\/mol.113.086470","article-title":"Therapeutic Cleavage of Anti-Aquaporin-4\u00a0Autoantibody in Neuromyelitis Optica by an IgG-Selective Proteinase","volume":"83","author":"Tradtrantip","year":"2013","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.revmed.2013.09.005_bib0385","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1681\/ASN.2009090984","article-title":"IgG Glycan Hydrolysis Attenuates ANCA-Mediated Glomerulonephritis","volume":"21","author":"Van Timmeren","year":"2010","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"10.1016\/j.revmed.2013.09.005_bib0390","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.molimm.2012.01.001","article-title":"An afucosylated anti-CD20\u00a0monoclonal antibody with greater antibody-dependent cellular cytotoxicity and B-cell depletion and lower complement-dependent cytotoxicity than rituximab","volume":"50","author":"Gasdaska","year":"2012","journal-title":"Molecular Immunology."}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866313006486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866313006486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:32:34Z","timestamp":1759336354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866313006486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":78,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0248866313006486"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2013.09.005","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycosylation des autoanticorps au cours des maladies auto-immunes","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2013.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}